APA (7th ed.) Citation

Li, J., Mo, M., Yu, K., Chen, C., Hu, Z., Hou, Y., . . . Liu, G. (2014). ER-poor and HER2-positive: A potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Li, Jian-Wei, et al. ER-poor and HER2-positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients After Neoadjuvant Chemo-trastuzumab Therapy. Public Library of Science (PLoS), 2014.

MLA (8th ed.) Citation

Li, Jian-Wei, et al. ER-poor and HER2-positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients After Neoadjuvant Chemo-trastuzumab Therapy. Public Library of Science (PLoS), 2014.